172 related articles for article (PubMed ID: 16552189)
1. Cdk5: a new player in pain signaling.
Pareek TK; Kulkarni AB
Cell Cycle; 2006 Mar; 5(6):585-8. PubMed ID: 16552189
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
3. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and orofacial pain sensation is unaffected by the loss of p39.
Prochazkova M; Hall B; Hu M; Okine T; Reukauf J; Binukumar BK; Amin ND; Roque E; Pant HC; Kulkarni A
Mol Pain; 2017; 13():1744806917737205. PubMed ID: 28969475
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.
Utreras E; Futatsugi A; Rudrabhatla P; Keller J; Iadarola MJ; Pant HC; Kulkarni AB
J Biol Chem; 2009 Jan; 284(4):2275-84. PubMed ID: 19049962
[TBL] [Abstract][Full Text] [Related]
6. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
[TBL] [Abstract][Full Text] [Related]
7. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
8. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
[TBL] [Abstract][Full Text] [Related]
9. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
[TBL] [Abstract][Full Text] [Related]
10. Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia.
Prochazkova M; Terse A; Amin ND; Hall B; Utreras E; Pant HC; Kulkarni AB
Mol Pain; 2013 Dec; 9():66. PubMed ID: 24359609
[TBL] [Abstract][Full Text] [Related]
11. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
[TBL] [Abstract][Full Text] [Related]
12. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
[TBL] [Abstract][Full Text] [Related]
13. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
Hallows JL; Chen K; DePinho RA; Vincent I
J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
[TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
[TBL] [Abstract][Full Text] [Related]
17. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
[TBL] [Abstract][Full Text] [Related]
18. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
19. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells.
Utreras E; Prochazkova M; Terse A; Gross J; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2013 May; 9():24. PubMed ID: 23668392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
